Exploring Pharmacists Attitudes, Practices, and Barriers to Conducting Medication Reviews in Community Pharmacy Settings
Main Article Content
Keywords
Pharmacist, medication review, practice, Attitude, community pharmacy
Abstract
Background: Medication review (MR) services are essential in optimizing therapy outcomes. In addition to the barriers hindering its adoption, understanding community pharmacists’ perception and practice of MR is crucial in formulating strategies to enhance MR services in pharmacy practice Objective: To evaluate pharmacists' attitudes, practices, and barriers to providing MR services in the community pharmacy setting. Methods: In this cross-sectional study, a validated self-administered questionnaire was distributed online to community pharmacists across the UAE using convenience-sampling technique. The questionnaire evaluated whether the pharmacists practiced MR, attitudes toward MR, the extent of its implementation, and the associated barriers. Stepwise regression was conducted to explore the variables associated with attitudes and MR practice. Results: The majority of the pharmacists (72.5%) reported providing MR, with a notable decline in engagement among older pharmacists (OR = 0.243, 95%Cl (0.113-0.522), employee pharmacists (OR = 0.909, 95% Cl (0.844-0.979) and those with no access to patient medication records (OR = 0.131, 95%Cl (0.052-0.327). The median attitude score was 27 out of 35, indicating favorable perceptions, particularly among pharmacists in chain pharmacies (OR = 2.974, 95%Cl (1.245-7.103). Employee pharmacists showed decreased odds of being in the high-attitude group (OR = 0.233, 95%Cl (0.076-0.714) and decreased odds to practice MR (OR = 0.192, 95%Cl (0.051-0.723) compared to pharmacists in charge or owner pharmacists. On the other hand, an increased number of working pharmacists (OR = 2.053, 95%Cl (1.381-3.052) and improved attitudes increased the odds to practice MR in the community pharmacy (OR = 2.617, 95%Cl (1.159-5.906). Conclusions: The study revealed a room for improvement in MR practice, especially among older and employee pharmacists. Enhancing the accessibility to specialized databases and authorized references, and enforcing pharmacists' attitudes towards MR practice via providing education and facilitating inter-professional collaboration are essential strategies to improve MR practice in the community pharmacy setting.
References
working in general practice: A Delphi study. Res Soc Adm Pharm. 2023;19(4):628-633. doi:10.1016/J.SAPHARM.2023.01.002
2. Thomson K, Hillier-Brown F, Walton N, Bilaj M, Bambra C, Todd A. The effects of community pharmacy-delivered public
health interventions on population health and health inequalities: A review of reviews. Prev Med (Baltim). 2019;124:98-109.
doi:10.1016/j.ypmed.2019.04.003
3. Almarsdóttir AB, Granas AG, Blondal AB. Clinical and Social Perspectives on Pharmacy Services. In: Thomas D, ed. Clinical
Pharmacy Education, Practice and Research. Elsevier; 2019:31-40. doi:10.1016/B978-0-12-814276-9.00003-9
4. NICE Medicines and Prescribing Centre (UK). Medicines Optimisation: The Safe and Effective Use of Medicines to Enable the
Best Possible Outcomes. National Institute for Health and Care Excellence (NICE); 2015.
5. Jarab AS, Al-Qerem W, Alzoubi KH, et al. Patterns of drug-related problems and the services provided to optimize drug therapy
in the community pharmacy setting. Saudi Pharm J. 2023;31(9):101746. doi:10.1016/j.jsps.2023.101746
6. Palaian S, Alomar M, Hassan N, Boura F. Opportunities for extended community pharmacy services in United Arab Emirates:
perception, practice, perceived barriers and willingness among community pharmacists. J Pharm Policy Pract. 2022;15:24.
doi:10.1186/s40545-022-00418-y
7. Rayes IK, Hassali MA, Abduelkarem AR. The role of pharmacists in developing countries: The current scenario in the United
Arab Emirates. Saudi Pharm J. 2015;23(5):470-474. doi:10.1016/j.jsps.2014.02.004
8. Koornneef E, Robben P, Blair I. Progress and outcomes of health systems reform in the United Arab Emirates: a systematic
review. BMC Health Serv Res. 2017;17(1):672. doi:10.1186/s12913-017-2597-1
9. Improving Good Health and Wellbeing in UAE: Challenges, Solutions, and Entrepreneurial Opportunities – Global Council for
the Promotion of International Trade.
10. Challenges Faced United Arb Emirates (UAE) Health Care System | Bartleby.
11. Basheti IA, Tadros OKI, Aburuz S. Value of a Community‐Based Medication Management Review Service in Jordan: A Prospective
Randomized Controlled Study. Pharmacother J Hum Pharmacol Drug Ther. 2016;36(10):1075-1086. doi:10.1002/phar.1833
12. Al-babtain B, Cheema E, Hadi MA. Impact of community-pharmacist-led medication review programmes on patient outcomes:
A systematic review and meta-analysis of randomised controlled trials. Res Soc Adm Pharm. 2022;18(4):2559-2568.
doi:10.1016/j.sapharm.2021.04.022
13. Yuan C, Ding Y, Zhou K, Huang Y, Xi X. Clinical outcomes of community pharmacy services: A systematic review and metaanalysis.
Health Soc Care Community. 2019;27(5):e567-e587. doi:10.1111/hsc.12794
14. Al-Arkee S, Al-Ani O. Community pharmacist-led interventions to improve medication adherence in patients with cardiovascular
disease: a systematic review of randomised controlled trials. Int J Pharm Pract. 2023;31(3):269-275. doi:10.1093/ijpp/riad013
15. Robberechts A, Van Loon L, Steurbaut S, De Meyer GRY, De Loof H. Patient experiences and opinions on medication review: a
qualitative study. Int J Clin Pharm. 2023;45(3):650-658. doi:10.1007/s11096-023-01541-9
16. Imfeld-Isenegger TL, Soares IB, Makovec UN, et al. Community pharmacist-led medication review procedures across
Europe: Characterization, implementation and remuneration. Res Soc Adm Pharm. 2020;16(8):1057-1066. doi:10.1016/j.
sapharm.2019.11.002
17. Brandt J, Lê ML, Jantscher S, et al. Medication review service implementation in community pharmacy settings: Scoping review
with focus on implementation studies. Res Soc Adm Pharm. 2020;16(7):875-885. doi:10.1016/j.sapharm.2019.10.005
18. Niquille A, Lattmann C, Bugnon O. Medication reviews led by community pharmacists in Switzerland: a qualitative survey to
evaluate barriers and facilitators. Pharm Pract. 2010;8(1). doi:10.4321/S1886-36552010000100004
19. Renfro CP, Turner K, Desai R, Counts J, Shea CM, Ferreri SP. Implementation process for comprehensive medication review in
the community pharmacy setting. J Am Pharm Assoc. 2019;59(6):836-841.e2. doi:10.1016/j.japh.2019.07.007
20. Medication review - Clinical Excellence Commission. Published online 2019.
21. Abu Assab M, Alhamad H, Almazari I, Azzam B, Abu Assab H. Barriers to Medication Review Process Implementation—Cross-
Sectional Study among Community Pharmacists in Jordan. Healthc. 2022;10(4):651. doi:10.3390/healthcare10040651
22. Jarab AS, Al-Qerem W, Mukattash TL, Abuhishmah SR, Alkhdour S. Pharmacists’ knowledge and attitudes toward medication
therapy management service and the associated challenges and barriers for its implementation. Saudi Pharm J. 2022;30(6):842-
848. doi:10.1016/j.jsps.2022.03.008
23. Rendrayani F, Alfian SD, Wahyudin W, Puspitasari IM. Knowledge, attitude, and practice of medication therapy management: a
national survey among pharmacists in Indonesia. Front Public Heal. 2023;11. doi:10.3389/fpubh.2023.1213520
24. Toklu HZ, Hussain A. The changing face of pharmacy practice and the need for a new model of pharmacy education. J Young
Pharm. 2013;5(2):38-40. doi:10.1016/j.jyp.2012.09.001
25. Craddock DS, Hall RG. Pharmacists Without Access to the EHR: Practicing with One Hand Tied Behind Our Backs. Inov Pharm.
2021;12(3):16. doi:10.24926/iip.v12i3.4141
26. Al-Tameemi NK, Sarriff A. Knowledge, attitude and practice of pharmacists on medication therapy management: a survey in
Hospital Pulau Pinang, Penang, Malaysia. J Pharm Heal Care Sci. 2019;5(1):1-9. doi:10.1186/s40780-019-0131-9 27. Shah B, Chawla S. A needs assessment for development and provision of medication therapy management services in New
York City. J Pharm Pract. 2011;24(3):339-344. doi:10.1177/0897190010396584
28. Adeoye OA, Lake LM, Lourens SG, Morris RE, Snyder ME. What predicts medication therapy management completion rates?
The role of community pharmacy staff characteristics and beliefs about medication therapy management. J Am Pharm Assoc.
2018;58(4):S7-S15.e5. doi:10.1016/j.japh.2018.03.001
29. Xi X, Huang Y, Lu Q, Ung COL, Hu H. Community pharmacists’ opinions and practice of pharmaceutical care at chain pharmacy
and independent pharmacy in China. Int J Clin Pharm. 2019;41(2):478-487. doi:10.1007/s11096-019-00802-w
30. Andayani T, Satibi S. Pharmacy Practice in Developing Countries: Achievements and Challenges. (Fathelrahman A, Ibrahim MI,
Wertheimer AI, eds.). Academic Press; 2016.
31. Jacobs S, Hann M, Bradley F, et al. Organisational factors associated with safety climate, patient satisfaction and self-reported
medicines adherence in community pharmacies. Res Soc Adm Pharm. 2020;16(7):895-903. doi:10.1016/j.sapharm.2019.09.058
32. Verma RK, Paraidathathu T, Taha NA, Chong WW. Attitudes, practices, and barriers of Malaysian community pharmacists
toward provision of weight management services. Front Pharmacol. 2019;10:1-11. doi:10.3389/fphar.2019.00138
33. Domiati S, Sacre H, Lahoud N, Sili G, Salameh P. Knowledge of and readiness for medication therapy management among
community pharmacists in Lebanon. Int J Clin Pharm. 2018;40(5):1165-1174. doi:10.1007/s11096-018-0666-0
34. Herbert KE, Urmie JM, Newland BA, Farris KB. Prediction of pharmacist intention to provide Medicare medication therapy
management services using the theory of planned behavior. Res Soc Adm Pharm. 2006;2(3):299-314. doi:10.1016/j.
sapharm.2006.02.008
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.